Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 1
1975 1
1976 1
1996 1
1997 2
1998 4
1999 6
2000 6
2001 12
2002 6
2003 14
2004 23
2005 13
2006 20
2007 46
2008 81
2009 79
2010 84
2011 120
2012 143
2013 154
2014 144
2015 113
2016 129
2017 119
2018 149
2019 166
2020 233
2021 255
2022 230
2023 195
2024 92

Text availability

Article attribute

Article type

Publication date

Search Results

2,026 results

Results by year

Filters applied: . Clear all
Page 1
Defining oligometastatic state in uro-oncological cancers.
Fazekas T, Miszczyk M, Matsukawa A, Nyirády P, Shariat SF, Rajwa P. Fazekas T, et al. Among authors: shariat sf. Curr Opin Urol. 2024 May 3. doi: 10.1097/MOU.0000000000001184. Online ahead of print. Curr Opin Urol. 2024. PMID: 38704827
Comparison of discovery rates and prognostic utility of [68Ga]Ga-PSMA-11 PET/CT and circulating tumor DNA in prostate cancer-a cross-sectional study.
Kluge K, Einspieler H, Haberl D, Spielvogel C, Amereller D, Egger G, Kramer G, Grubmüller B, Shariat S, Hacker M, Kenner L, Haug A. Kluge K, et al. Among authors: shariat s. Eur J Nucl Med Mol Imaging. 2024 May 2. doi: 10.1007/s00259-024-06698-7. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38693454
Radiographic Progression Without Corresponding Prostate-specific Antigen Progression in Patients with Metastatic Castration-sensitive Prostate Cancer Receiving Apalutamide: Secondary Analysis of the TITAN Trial.
Fukuokaya W, Yanagisawa T, Mori K, Urabe F, Rajwa P, Briganti A, Shariat SF, Kimura T. Fukuokaya W, et al. Among authors: shariat sf. Eur Urol Oncol. 2024 Apr 29:S2588-9311(24)00101-9. doi: 10.1016/j.euo.2024.04.009. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38688767
The effect of married status on cancer-specific mortality in nonmetastatic pelvic liposarcoma patients according to sex.
Baudo A, Morra S, Scheipner L, Jannello LMI, de Angelis M, Siech C, Touma N, Goyal JA, Tian Z, Acquati P, Longo N, Ahyai S, de Cobelli O, Briganti A, Chun FKH, Saad F, Shariat SF, Carmignani L, Karakiewicz PI. Baudo A, et al. Among authors: shariat sf. World J Surg. 2024 Jan;48(1):97-103. doi: 10.1002/wjs.12040. Epub 2023 Dec 18. World J Surg. 2024. PMID: 38686806
Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
Scheipner L, Baudo A, Jannello LMI, Siech C, de Angelis M, Tian Z, Saad F, Shariat SF, Briganti A, Chun FKH, Carmignani L, De Cobelli O, Mischinger J, Ahyai S, Karakiewicz PI. Scheipner L, et al. Among authors: shariat sf. World J Urol. 2024 Apr 28;42(1):269. doi: 10.1007/s00345-024-04940-3. World J Urol. 2024. PMID: 38679642
Assessment of PSMA Expression of Healthy Organs in Different Stages of Prostate Cancer Using [68Ga]Ga-PSMA-11-PET Examinations.
Einspieler H, Kluge K, Haberl D, Schatz K, Nics L, Schmitl S, Geist BK, Spielvogel CP, Grubmüller B, Baltzer PAT, Kramer G, Shariat SF, Hacker M, Rasul S. Einspieler H, et al. Among authors: shariat sf. Cancers (Basel). 2024 Apr 16;16(8):1514. doi: 10.3390/cancers16081514. Cancers (Basel). 2024. PMID: 38672596 Free PMC article.
2,026 results